Articles in Prescription Drugs
Drug giant Pfizer to pay record $2.3 billion fine
CNN reports that the Justice Department has announced that pharmaceutical giant Pfizer “has agreed to pay a record $2.3 billion settlement to resolve criminal and civil liability for illegally promoting certain pharmaceuticals.”
Document Details Forest Labs’ Plan to Promote Costly Drug Lexapro
The New York Times reports that while the pharmaceutical industry “has developed thousands of medicines that have saved millions of lives, it has also used its marketing muscle to successfully peddle expensive pills that are no more effective than older drugs sold at a fraction of the cost.”
FDA Warns Maker of Acne Drug to Halt Alleged Misleading Advertising
A recent warning letter to pharmaceutical company Allergan Inc. by the U.S. Food and Drug Administration could be a prelude to suits by states, according to legal experts. At least one noted that the tone and wording of the FDA’s letter was the harshest in recent memory.
Timeline Announced for Withdrawal of Raptiva from European Market
The European Medicines Agency (EMEA) posted a public statement in which it announced the timeline for the withdrawl of the marketing authorization for the psoriasis drug Raptiva (efalizumab).
Women’s Health Alert: Yaz & Yasmin Lawsuits
Lawsuits have been filed against Bayer, the manufacturer of Yaz and Yasmin, alleging the company failed to adequately warn patients and physicians of the increased risk of serious adverse effects from Yasmin and Yaz, while touting the birth control advantages of the drugs in television advertisements.
